Corporate Investor Profile
In the last 3 years, Novo Holdings A/S has acquired 5 companies.
Novo Holdings A/S’s most common sectors for investment arelife science (38%) and diversified (13%) . The Firm’s most common investment types include secondary buyout (75%) and recapitalization (13%). In total, Novo Holdings A/S has invested in 3 US states and 5 different countries. Its largest (disclosed) acquisition occurred in 2013 when it acquired Xellia Pharmaceuticals AS for $700M.
In the last 3 years, Novo Holdings A/S has exited 1 company. The Firm’s most common exit type is secondary buyout (100%). Novo Holdings A/S’s largest (disclosed) exit occurred in 2021 when it sold Unchained Labs for $435M.
Join Mergr to view Novo Holdings A/S’s full profile and discover more middle-market private equity firms just like it.
M&A Summary
-
M&A Total Activity9
- M&A Buy Activity8
- M&A Sell Activity1
- Total Sectors Invested 6
- Total Countries Invested 5
- M&A Advisors 5
Unlimited Searches
